DocuSign price target raised to $65 from $56 at Wedbush

Wedbush raised the firm’s price target on DocuSign to $65 from $56 and keeps a Neutral rating on the shares. DocuSign’s Q4 results featured beats on the top and bottom-line as the company continues to see strength core technology while improving the reach of its go-to-market initiatives and further improvements in operating leverage in the business model, the analyst tells investors in a research note. At the same time, the firm believes it will take more time to create more confidence with the Street with the AI story starting to pick up.